EWA
PYXS icon

EverSource Wealth Advisors’s Pyxis Oncology PYXS Stock Holding History

EverSource Wealth Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-434
Closed -$964 – 4406
2025
Q3 		$964 Sell
434
-157
-27% -$226 ﹤0.01% 3770
2025
Q2 		$650 Buy
591
+107
+22% +$121 ﹤0.01% 3833
2025
Q1 		$474 Buy
+484
New +$646 ﹤0.01% 3475

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EverSource Wealth Advisors's PYXS Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Pyxis Oncology (PYXS) in Q4 2025, closing a stake of 434 shares — an estimated $964 sold.

EverSource Wealth Advisors first reported a position in PYXS in Q1 2025 and held it in 3 quarters. The position peaked at $964 in Q3 2025. 79 funds tracked by Wall St. Rank hold PYXS as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining Pyxis Oncology position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 434 Pyxis Oncology shares in Q4 2025, an estimated $964.
  • EverSource Wealth Advisors first reported a position in Pyxis Oncology in Q1 2025 and held it in 3 quarters.
  • EverSource Wealth Advisors's Pyxis Oncology position peaked at $964 in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.